IV Insulin Protocol in Diabetes and Renal Transplantation
Completed · Not applicable
Conditions studied: Kidney Transplantation, Diabetes, Hyperglycemia
In brief
Purpose: The purpose of this study is to provide tight blood sugar control using insulin given through the veins at the time of kidney transplantation and up to 3 days after surgery. After release from the hospital, the patient will control blood sugar with subcutaneous insulin injections or pills. With this approach, outcomes should improve for diabetic transplant patients such as longer life of the new kidney, fewer hospital readmissions, decreased associated infections, and other advantages. Hypothesis: It is hypothesized that intensive glycemic control will lead to better clinical and biochemical outcomes and improved long-term graft survival.
Key facts
- Study ID
- NCT00609986
- Run by
- Medical University of South Carolina
- People needed
- 104
- Starts
- 2007-07-01
- Expected to finish
- 2010-10-01
- Last updated by the study team
- 2013-09-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age and greater,
- Diabetes diagnosis (Type 1 and Type 2, awaiting a living or cadaveric renal transplant, renal transplant candidates admitted to MUSC medical center for a donor kidney, FBG >100 mg/dL per admission screening labs, random BG >120mg/dL per admission screening labs, and
- Willing and able to provide informed consent
You may not qualify if…
- History of an active GI bleed in the previous 3 mos,
- Scheduled to receive a simultaneous pancreas transplant,
- History of a functioning pancreatic transplant,
- Patient currently managed on an insulin pump,
- Unable or unwilling to provide informed consent, and
- Unable to commit to the study protocol including the outpatient follow-up phase of care
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.